49 PATENTS GRANTED PATENTS Method for the diagnosis of airway disease inflammatory subtype (Schleich F, Louis R, Bessonov K, Van Steen K, Schooten FJ, Dallinga J), prior. filing date: 21st Sept. 2015, Patents granted in Australia and USA, ref. AU2016328384B2, US11406280B2 Cyclodextrin and budesonide derivative compositions and methods (Maes P, Cataldo D, Evrard B, Dufour G, De Tullio P), prior. filing date: 28th March 2014, Patents granted in China, Japan and South Korea, ref. CN106413759B, JP7008097B2, KR102391676B1 Nanoreservoirs (Oury C, Jérôme C, Detrembleur C, Lancellotti P), Prior. filing date: 28 Dec. 2016, Patent granted in Malaysia, ref. MY192938A Triazolo (4,5-D) pyrimidine derivatives for use in the prevention and treatment of bacterial infection (Oury C, Lancellotti P), prior. filing date: 9th Sept. 2016, Patents granted in Japan and South Korea, ref. JP7075667, KR102401152B1 Pyrimidine derivatives for prevention and treatment of bacterial infection (Oury C, Lancellotti P, Pirotte B), prior. filing date: 14th Febr 2018, Patent granted in Europe and USA, ref. EP3752506B1, US11434241B2 Monitoring method for adult T-cell leukemia/lymphoma (ATL) (Van den Broeke A, Georges M, Durkin K, Artesi M, Hahaut V, Rosewick N), prior. filing date: 6th April 2017, Patent granted in Japan, ref. JP7066826 Translation assay for codons sensitive to tRNA modification using a luminescence-based reporter system (Close P, Rapino F, Chariot A), prior. filing date: 29 March 2021, Patent granted in Belgium, ref. BE1028737B1 Cell-free FRET screening of tRNA fragments and competition assay for inhibitors of human tRNA-modifying enzymes useful in the treatment or prevention of tRNA-modifying conditions (Close P, Rapino F, Chariot A), prior. filing date: 13th August 2021, Patent granted in Belgium, ref. BE1029219B1 Container system for receiving a liquid sample (Bureau F, Gillet L, Bureau C), prior. filing date: 15th July 2020, Patent granted in Europe, ref. EP3939700B1 PUBLISHED PATENT DOCUMENTS New pyrimidine derivatives for prevention and treatment of gram-negative bacterial infection, contamination and fouling (Lancellotti P, Oury C, Pirotte B, Musumeci L, Jacques N, Goffin E), prior. filing date: 18th Apr 2019 ; 26th Jul 2019 , ref. EP3955929A1 Cyclodextrin used in the treatment and prevention of latephase bronchoconstriction in allergen-induced asthma (Cataldo D, Evrard B), prior. filing date: 15th June 2020, ref. : MA53516A1 Container system for receiving a liquid sample (Bureau F, Gillet L, Bureau C), prior. filing date: 15th July 2020, ref.: WO2022013235A1 Agonists of human kisspeptin receptor for modulating sexual desire (Bakker J, Ouerdi S), prior. filing date: 24th January 2019, Ref. US2022040253A1 Method for the diagnosis of airway disease inflammatory subtype ((Schleich F, Louis R, Bessonov K, Van Steen K, Schooten FJ, Dallinga J), prior. filing date: 21st Sept. 2015, Ref. EP3936045A1 Use of Triazolo(4,5-d)pyrimidine derivatives (Oury C, Lancellotti P, Nchimi A, Luxen A, Goffin E, Stouse A), prior. filing date: 25th July 2019, Ref. US2022143226A1 Anti-CD38 single-domain antibodies in disease monitoring and treatment (Caers J, Dumoulin M, Duray E, d’Huyvetter M, Erikson Karlström A), prior. filing date: 17th May 2021, Ref. : WO2022242892A1 Extracellular vesicles containing MIR-142-3P to treat fibrosing diseases (Struman I, Njock MS, Guiot J), prior. filing date: 16th July 2019, Ref. US2022313723A1 New antimicrobial and antithrombogenic medical device (Lancellotti P, Oury C, Jérôme Ch, Detrembleur Ch, Aqil A, Melo S, Pierrard A), prior. filing date: 26th Febr 2021, Ref. WO2022180235A1 Small molecule disruptors of protein interactions in histone deacetylase complexes (Olivet J, Choi SG, Twizere JC, Vidal M, Buhrlage S), prior. filing date: 17th June 2021, Ref. WO2022266473A1
RkJQdWJsaXNoZXIy MTk1ODY=